SCHEMBL24745136

SCHEMBL24745136

O=C(O)c1[nH]c2c(Br)cccc2c1CCCOc1cccc2ccccc12

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 17/20 0.75
BCL2 P10415 4/20 0.72
ALB P02768 1/20 0.72
BCL2L1 Q07817 3/20 0.63
PRKCD Q05655 4/20 0.62
CAMK2B Q13554 4/20 0.62
CAMK2G Q13555 4/20 0.62
MARK3 P27448 3/20 0.62
NEK4 P51957 3/20 0.62
CAMK2D Q13557 3/20 0.62
MARK2 Q7KZI7 3/20 0.62
PIM3 Q86V86 3/20 0.62
HIPK2 Q9H2X6 3/20 0.62
MAP3K20 Q9NYL2 3/20 0.62
MAP4K5 Q9Y4K4 3/20 0.62
AXL P30530 2/20 0.62
MKNK2 Q9HBH9 2/20 0.62
EEF2K O00418 1/20 0.62
BCL6 P41182 1/20 0.62
PRKAA1 Q13131 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30000856 1.00 MCL1 (0.75) MCL1BCL2ALBBCL2L1PRKCD
SCHEMBL4161471 0.89 MCL1 (0.92) MCL1BCL2ALBBCL2L1PRKCD
SCHEMBL4164705 0.88 MCL1 (0.77) MCL1BCL2ALBBCL2L1PRKCD
SCHEMBL4165286 0.87 MCL1 (0.60) MCL1BCL2ALBBCL2L1PRKCD
SCHEMBL4166750 0.87 MCL1 (0.88) MCL1BCL2ALBBCL2L1PRKCD
SCHEMBL4165474 0.86 MCL1 (1.00) MCL1BCL2ALBBCL2L1PRKCD
SCHEMBL24745357 0.86 MCL1 (0.58) MCL1BCL2ALBBCL2L1PRKCD
SCHEMBL30000839 0.86 MCL1 (0.58) MCL1BCL2ALBBCL2L1PRKCD
SCHEMBL15622814 0.85 MCL1 (0.77) MCL1BCL2ALBBCL2L1
SCHEMBL4162155 0.85 MCL1 (1.00) MCL1BCL2ALBBCL2L1PRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117957218-A Targeted protein degradation using bifunctional compounds that bind to ubiquitin ligases and target MCL-1 proteins 凯普托尔治疗学股份有限公司 2024-04-30 CN disclosed
WO-2022255888-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 WO disclosed
WO-2022253713-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 WO disclosed